St. Paul's Hospital

Running trials

• Recruiting

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· Phase 3· Source

• Recruiting

  SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure

  NCT06955260· Phase 3· Source

• Recruiting

  Canadian Consortium on Airway Mucus Occlusions in Asthma, COPD and Chronic Cough

  NCT06858748· Source

• Recruiting

  Effects of Salbutamol in Athletes and Implications for Screening and Sports

  NCT07037511· Source

• Recruiting

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06935357· Phase 3· Source

• Recruiting

  Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  NCT06736574· Phase 3· Source

• Active, not recruiting

  Phase 2b Open-Label Repeat Kidney Biopsy Study

  NCT06740526· Phase 2· Source

• Recruiting

  Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  NCT06217302· Phase 3· Source

• Active, not recruiting

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· Phase 3· Source

• Active, not recruiting

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· Phase 3· Source

• Recruiting

  Skeletal Muscle Function in Interstitial Lung Disease

  NCT03800017· Source

• Recruiting

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· Phase 3· Source

• Recruiting

  The ReTAVI Prospective Observational Registry

  NCT05601453· Source

• Recruiting

  Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

  NCT05955924· Phase 3· Source

• Active, not recruiting

  Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  NCT05701358· Source

• Active, not recruiting

  Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

  NCT05462145· Source

• Active, not recruiting

  Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del

  NCT05331183· Phase 3· Source

• Active, not recruiting

  RESPONDER-HF Trial

  NCT05425459· Source

• Active, not recruiting

  A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

  NCT05444257· Phase 3· Source

• Active, not recruiting

  A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

  NCT05481151· Phase 3· Source

• Active, not recruiting

  A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

  NCT05482971· Phase 2· Source

• Enrolling by invitation

  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  NCT04905693· Phase 3· Source

• Recruiting

  St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)

  NCT05402696· Source

• Active, not recruiting

  Microbiota Transfer for Chronic Rhinosinusitis

  NCT05454072· Source

• Recruiting

  Trikafta Exercise Study in Cystic Fibrosis

  NCT05279040· Source

• Recruiting

  Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF

  NCT05200429· Source

• Active, not recruiting

  STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation

  NCT04428944· Source

• Active, not recruiting

  Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

  NCT04279847· Phase 1· Source

• Enrolling by invitation

  A Long-term Follow-up Study in Participants Who Received CTX001

  NCT04208529· Phase 3· Source

• Recruiting

  Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

  NCT04634240· Source

• Active, not recruiting

  Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

  NCT04285086· Phase 3· Source

• Active, not recruiting

  Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis

  NCT04217356· Source

• Recruiting

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  NCT03573089· Source

• Active, not recruiting

  SyncAV Post-Market Trial

  NCT04100148· Source

• Enrolling by invitation

  Hearts in Rhythm Organization (HiRO)National Registry and Bio Bank

  NCT04189822· Source

• Active, not recruiting

  Reversal of Atrial Substrate to Prevent Atrial

  NCT03682991· Source

• Active, not recruiting

  LEADERS FREE II: BioFreedom™ Pivotal Study

  NCT02843633· Source

• Active, not recruiting

  A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

  NCT02993523· Phase 3· Source

• Active, not recruiting

  Edwards EVOQUE Eos MISCEND Study

  NCT02718001· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Idiopathic pulmonary fibrosis3 recruiting
• Asthma2 recruiting
• Chronic kidney disease2 recruiting
• Cystic fibrosis2 recruiting
• Heart failure2 recruiting
• COPD1 recruiting
• Coronary artery disease1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• IgA nephropathy1 recruiting
• Melanoma1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Sickle cell disease1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Thalassaemia1 recruiting
• Type 1 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Post-Discharge Pharmacist-led Rapid Medication Optimization for Heart Failure (Post-Discharge PHARM-HF)

  NCT06450522· Source

• Completed

  A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada

  NCT06549608· Source

• Completed

  A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

  NCT06064929· Phase 1· Source

• Terminated

  Nabilone for Agitation in Frontotemporal Dementia

  NCT05742698· Phase 2· Source

• Completed

  A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

  NCT05559580· Phase 2· Source

• Terminated

  A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)

  NCT05568225· Phase 2· Source

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· Phase 3· Source

• Completed

  IBD Neoplasia Surveillance RCT

  NCT05809999· Source

• Completed

  A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Myelofibrosis Through Chart Review

  NCT05444972· Source

• Completed

  A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

  NCT05076149· Phase 3· Source

• Completed

  RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department

  NCT04485195· Phase 4· Source

• Completed

  Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT04708782· Phase 3· Source

• Completed

  Combination Antiretroviral Therapy (cART) for PBC

  NCT03954327· Phase 2· Source

• Completed

  Interactive Online Informational and Peer Support App for Patients with Low Anterior Resection Syndrome

  NCT04469426· Source

• Completed

  Registry of Asthma Patients Initiating DUPIXENT®

  NCT04287621· Source

• Terminated

  The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO

  NCT04029233· Source

• Completed

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· Phase 3· Source

• Completed

  HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection

  NCT03575910· Source

• Completed

  A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

  NCT03573310· Phase 1· Source

• Completed

  NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer

  NCT03259035· Phase 2· Source

• Completed

  Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)

  NCT03269110· Source

• Completed

  CardiAMP™ Cell Therapy for Heart Failure Trial

  NCT02438306· Phase 3· Source

• Completed

  Antiarrhythmics or Ablation for Ventricular Tachycardia 2

  NCT02830360· Phase 4· Source

• Completed

  Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

  NCT02168829· Phase 4· Source

• Completed

  High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib

  NCT02551068· Source

• Completed

  Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

  NCT01938248· Phase 4· Source

• Completed

  A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

  NCT02158858· Phase 1/2· Source

• Completed

  Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

  NCT00673842· Phase 3· Source

• Completed

  Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

  NCT00853632· Source

Trial sites

• Heart Rhythm Research Office - St. Paul's Hospital1 trial
• St. Paul's Hospital48 trials
• St. Paul's Hospital - Hematology1 trial
• St. Paul's Hospital /ID# 1596441 trial
• St. Paul's Hospital /ID# 2497191 trial
• St. Paul's Hospital - Providence Health Care3 trials
• St. Paul's Hospital - Pulmonology1 trial
• St. Paul'S Hospital (Sph), Providence Health Care, University of British Columbia1 trial
• St Paul's Hospital, University of British Columbia1 trial
• St. Paul's Hospital, Vancouver5 trials
• St. Paul's Hospital, Vancouver, BC1 trial
• UBC Centre for Heart Lung Innovation, St. Paul's Hospital1 trial
• University of British Columbia/St. Paul's Hospital3 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Cystic fibrosis17 works · 5 trials
• Idiopathic pulmonary fibrosis11 works · 7 trials